cdsco news
Latest from cdsco
Govt bans 35 fixed-dose combo drugs from manufacture, sale
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.
Published on Apr 16, 2025 08:26 PM IST
PTI |
Data flags 19 spurious drug samples detected in 2024
The Central Drugs Standard Control Organisation (CDSCO) has listed at least 135 drugs and formulations as not of standard quality (NSQ) for December last year
Updated on Jan 25, 2025 07:34 AM IST
Rhythma Kaul, New Delhi
Why India waiving off clinical trials for globally approved drugs is good news
The CDSCO's decision is aimed at speeding up the introduction of advanced drugs in India, particularly benefiting patients who would otherwise face delays
Published on Aug 12, 2024 08:00 AM IST
The science of tirzepatide, touted as a game-changing weight loss drug
So far, common side effects of tirzepatide include nausea and vomiting. This newly approved new drug is not the only one that can treat obesity and diabetes
Published on Jul 24, 2024 09:00 AM IST
Nandita Jayaraj
22 made-in-Himachal drug samples fail quality test
The central drug control organisation had drawn samples from across the country in May. It found that 52 samples did not meet the standards, of which 22 were manufactured in Himachal. The state drug controlling authorities have asked the erring industries to call back the stocks of failed samples from the market.
Updated on Jun 23, 2024 06:40 AM IST
Gaurav Bisht, Shimla
Drug regulator flags quality issues, sends notices to 12 firms in Himachal
The samples of medicines manufactured in Himachal whose samples have failed include medicines and injections for the treatment of cancer, heart disease, infection, fever, vomiting, gastric, edema, cholesterol, pneumonia and stomach worms
Updated on Dec 25, 2023 06:00 AM IST
Gaurav Bisht, Shimla
CDSCO set to ban these common cold, flu syrups for children under four years
The SEC emphasised that the specified combination should not be administered to children below four years of age.
Published on Dec 20, 2023 10:37 PM IST
Drug regulator flags quality issues, shoots off notices to 19 firms in HP
Twenty four medicines from 19 Himachal-based industries fail to meet standards; tainted drugs are used for critical health conditions, including fungal infections, cancer, type 2 diabetes, bacterial infections
Updated on Nov 22, 2023 05:00 AM IST
Gaurav Bisht, Shimla
3 more drug combinations under govt’s lens
A fixed dose combination (FDC) is the combination of two or more drugs in certain fixed doses
Updated on Jun 19, 2023 12:25 AM IST
Tamil Nadu firm told to suspend eye drops’ manufacturing
The manufacturers were directed to “stop the manufacturing activities of all the products under the category of ophthalmic preparations till the completion of investigation”, the report added.
Updated on Feb 05, 2023 09:28 AM IST
Soumya Pillai and Divya Chandrababu, New Delhi/chennai
CDSCO inspects drugs factory for compliance
India’s pharmaceutical standards authority has started random inspections of drug factories to check for regulatory compliance, the health ministry announced on Tuesday, a fallout of an Indian company’s cough syrups being linked to deaths in Gambia.
Updated on Dec 28, 2022 05:01 AM IST
Cough syrups probe: Haryana firm keeps shut as Centre takes steps to curb damage
The Central Drugs Standard Control Organisation, the top drug regulatory authority of India, has launched an inquiry and alerted the Haryana government last week after learning about The Gambia tragedy.
Updated on Oct 07, 2022 12:48 PM IST
Cosmetic makers can’t be mandated to put veg, non-veg labels, HC told
In an affidavit, the CDSCO said that the Drugs Technical Advisory Board (DTAB) has not “agreed for mandating green (for vegetarian) or red (for non-vegetarian) dot on every packet of cosmetic as it may complicate the regulation and add regulatory burden on the stakeholders”.
Updated on Jan 22, 2022 03:53 AM IST
Richa Banka, Hindustan Times, New Delhi
Covishield shelf life extended from 6 to 9 months: Govt
Concerns regarding Covid-19 vaccine wastage were raised as SII began production of the Covid-19 vaccine before being granted emergency use authorisation for use in India on January 3.
Updated on Mar 31, 2021 06:19 AM IST
Rhythma Kaul, New Delhi